Eve Health Group Limited has released a press release.
New Probiotic Product Range - Additional Information
Filed with ASX ·
6ix hasn’t read this filing yet.
EVE Health Group Limited on 6ix
Story so far
Earlier from EVE Health
- Meluka Sales Performance Drives New Probiotic Product Range
- Appendix 4C - June Quarter 2021 - Amended
- Appendix 4C - June Quarter 2021
- Appendix 4C - March Quarter 2021
- Company Update
Later from EVE Health
- Appendix 4C - September Quarter 2021
- Alliance Agreement - Australian Sales Force
- Alliance Agreement - Additional Information
- Change of Director's Interest Notice x 3
- Meluka Australia - Half Year Update
Follow EVE Health into a list and get an email when it puts out news.
Follow EVE Health